Sino Biopharmaceutical | 1177 - Cash And Equivalent

Stock Price
6.15
Daily Change
-0.24 -3.76%
Monthly
-7.80%
Yearly
78.78%
Q1 Forecast
6.38

Sino Biopharmaceutical reported CNY3.38B in Cash and Equivalent for its fiscal semester ending in December of 2024.





Cash And Equivalent Change Date
Akebia Therapeutics USD 184.84M 18.4M Dec/2025
Alaunos Therapeutics USD 1.94M 941K Sep/2025
Avita Medical AUD 12.22M 1.83M Jun/2025
Cspc Pharmaceutical CNY 7.57B 793.73M Jun/2025
Dianthus Therapeutics USD 55.98M 42.75M Sep/2025
Ionis Pharmaceuticals USD 2.68B 437M Dec/2025
IQVIA Holdings USD 1.98B 166M Dec/2025
Jiangsu Hengrui CNY 40.36B 4.24B Sep/2025
Moderna USD 2.6B 1.46B Dec/2025
Organon & Co USD 672M 73M Sep/2025
Revvity USD 919.86M 11.53M Dec/2025
Sino Biopharmaceutical CNY 3.38B 2.09B Dec/2024
Tectonic Therapeutic USD 268.44M 18.94M Sep/2025
Viatris USD 975.3M 408.9M Sep/2025
Xeris Pharmaceuticals USD 91.6M 32.32M Sep/2025